Comment on

• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Clinical Trial.
• Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results.

  Bolli GB, Consoli A, Giaccari A. Bolli GB, et al. Nutr Metab Cardiovasc Dis. 2012 Dec;22(12):1007-12. doi: 10.1016/j.numecd.2012.10.004. Nutr Metab Cardiovasc Dis. 2012. PMID: 23199612